Nancy Bartlett

2024

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

Merryman, R. W., Redd, R. A., Freedman, A. S., Ahn, I. E., Brown, J. R., Crombie, J. L., Davids, M. S., Fisher, D. C., Jacobsen, E. D., Kim, A. I., LaCasce, A. S., Ng, S., Odejide, O. O., Parry, E. M., Isufi, I., Kline, J., Cohen, J. B., Mehta-Shah, N., Bartlett, N. L. & Mei, M. & 5 others, Kuntz, T. M., Wolff, J., Rodig, S. J., Armand, P. & Jacobson, C. A., Jan 2024, In: Annals of Hematology. 103, 1, p. 185-198 14 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Ghobadi, A., Foley, N. C., Cohen, J., Rettig, M. P., Cashen, A. F., Gehrs, L., Christ, S., Street, E., Wallace, N., Ritchey, J., Mehta-Shah, N., Westervelt, P., Fehniger, T. A., Kahl, B., Bartlett, N. L. & DiPersio, J. F., Feb 13 2024, In: Blood Advances. 8, 3, p. 513-522 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Durable Responses with Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Budde, L. E., Assouline, S., Sehn, L. H., Schuster, S. J., Yoon, S. S., Yoon, D. H., Matasar, M. J., Bosch, F., Kim, W. S., Nastoupil, L. J., Flinn, I. W., Shadman, M., Diefenbach, C., Cheah, C. Y., Ma, C. Y., Huang, H., Kwan, A., Wei, M. C., Yin, S. & Bartlett, N. L., Jul 1 2024, In: Journal of Clinical Oncology. 42, 19, p. 2250-2256 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

Woyach, J. A., Perez Burbano, G., Ruppert, A. S., Miller, C., Heerema, N. A., Zhao, W., Wall, A., Ding, W., Bartlett, N. L., Brander, D. M., Barr, P. M., Rogers, K. A., Parikh, S. A., Stephens, D. M., Brown, J. R., Lozanski, G., Blachly, J., Nattam, S., Larson, R. A. & Erba, H. & 12 others, Litzow, M., Luger, S., Owen, C., Kuzma, C., Abramson, J. S., Little, R. F., Dinner, S., Stone, R. M., Uy, G., Stock, W., Mandrekar, S. J. & Byrd, J. C., Apr 18 2024, In: Blood. 143, 16, p. 1616-1627 12 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids

Oluwole, O. O., Forcade, E., Muñoz, J., de Guibert, S., Vose, J. M., Bartlett, N. L., Lin, Y., Deol, A., McSweeney, P., Goy, A. H., Kersten, M. J., Jacobson, C. A., Farooq, U., Minnema, M. C., Thieblemont, C., Timmerman, J. M., Stiff, P., Avivi, I., Tzachanis, D. & Zheng, Y. & 6 others, Vardhanabhuti, S., Nater, J., Shen, R. R., Miao, H., Kim, J. J. & van Meerten, T., Mar 2024, In: Bone Marrow Transplantation. 59, 3, p. 366-372 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas

Schuster, S. J., Huw, L. Y., Bolen, C. R., Maximov, V., Polson, A. G., Hatzi, K., Lasater, E. A., Assouline, S. E., Bartlett, N. L., Budde, L. E., Matasar, M. J., Koeppen, H., Piccione, E. C., Wilson, D., Wei, M. C., Yin, S. & Penuel, E., Feb 29 2024, In: Blood. 143, 9, p. 822-832 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial

Cottereau, A. S., Rebaud, L., Trotman, J., Feugier, P., Nastoupil, L. J., Bachy, E., Flinn, I. W., Haioun, C., Ysebaert, L., Bartlett, N. L., Tilly, H., Casasnovas, O., Ricci, R., Portugues, C., Buvat, I., Meignan, M. & Morschhauser, F., Jan 2024, In: Annals of Oncology. 35, 1, p. 130-137 8 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial

Matasar, M., Bartlett, N. L., Shadman, M., Budde, L. E., Flinn, I., Gregory, G. P., Kim, W. S., Hess, G., El-Sharkawi, D., Diefenbach, C. S., Huang, H., To, I., Parreira, J., Wu, M., Kwan, A. & Assouline, S., Apr 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 4, p. 240-253 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

4 Scopus citations

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Batchelor, T. T., Giri, S., Ruppert, A. S., Geyer, S. M., Smith, S. E., Mohile, N., Swinnen, L. J., Friedberg, J. W., Kahl, B. S., Bartlett, N. L., Hsi, E. D., Cheson, B. D., Wagner-Johnston, N., Nayak, L., Leonard, J. P. & Rubenstein, J. L., Jun 25 2024, In: Blood Advances. 8, 12, p. 3189-3199 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study

Rezazadeh, A., Szabo, A., Khurana, A., Inwards, D. J., Lunning, M. A., Bartlett, N. L., Caimi, P. F., Rodgers, T. D., Barr, P. M., Chowdhury, S. M., Epperla, N., Mendries, H., Hill, B. T., Oh, T. S., Karmali, R., Chang, J. E., Goyal, G., Parsons, B. M., Isaac, K. M. & Portell, C. A. & 4 others, Monahan, K., Siker, M., King, D. M. & Fenske, T. S., May 1 2024, In: Haematologica. 109, 5, p. 1439-1444 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

2023

B-Cell Lymphomas, Version 6.2023 Featured Updates to the NCCN Guidelines

Zelenetz, A. D., Gordon, L. I., Abramson, J. S., Advani, R. H., Andreadis, B., Bartlett, N. L., Budde, L. E., Caimi, P. F., Chang, J. E., Christian, B., DeVos, S., Dholaria, B., Fayad, L. E., Habermann, T. M., Hamid, M. S., Hernandez-Ilizaliturri, F., Hu, B., Kaminski, M. S., Karimi, Y. & Kelsey, C. R. & 18 others, King, R., Krivacic, S., LaCasce, A. S., Lim, M., Messmer, M., Narkhede, M., Rabinovitch, R., Ramakrishnan, P., Reid, E., Roberts, K. B., Saeed, H., Smith, S. D., Svoboda, J., Swinnen, L. J., Tuscano, J., Vose, J. M., Dwyer, M. A. & Sundar, H., 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 11, p. 1118-1131 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies

Patel, D. A., Wan, F., Trinkaus, K., Guy, D. G., Edwin, N., Watkins, M., Bartlett, N. L., Cashen, A., Fehniger, T. A., Ghobadi, A., Shah, N. M. & Kahl, B. S., Jul 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 7, p. 552-560 9 p.

Research output: Contribution to journal › Article › peer-review

Cell-of-origin effect of polatuzumab vedotin in diffuse large B-cell lymphoma: no ordinary subgroup analysis

Russler-Germain, D. A., Cliff, E. R. S. & Bartlett, N. L., Dec 21 2023, In: Blood. 142, 25, p. 2216-2219 4 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma

Roddie, C., Lekakis, L. J., Marzolini, M. A. V., Ramakrishnan, A., Zhang, Y., Hu, Y., Peddareddigari, V. G. R., Khokhar, N., Chen, R., Basilico, S., Raymond, M., Vargas, F. A., Duffy, K., Brugger, W., O'Reilly, M. A., Wood, L., Linch, D. C., Peggs, K. S., Bachier, C. & Budde, E. L. & 7 others, Lee Batlevi, C., Bartlett, N., Irvine, D., Tholouli, E., Osborne, W., Ardeshna, K. M. & Pule, M. A., May 18 2023, In: Blood. 141, 20, p. 2470-2482 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

35 Scopus citations

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

Neelapu, S. S., Jacobson, C. A., Ghobadi, A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., Deol, A., Reagan, P. M., Stiff, P., Flinn, I. W., Farooq, U., Goy, A. H., McSweeney, P. A., Munoz, J., Siddiqi, T. & Chavez, J. C. & 10 others, Herrera, A. F., Bartlett, N. L., Bot, A. A., Shen, R. R., Dong, J., Singh, K., Miao, H., Kim, J. J., Zheng, Y. & Locke, F. L., May 11 2023, In: Blood. 141, 19, p. 2307-2315 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

150 Scopus citations

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Thomas, N., Dreval, K., Gerhard, D. S., Hilton, L. K., Abramson, J. S., Ambinder, R. F., Barta, S., Bartlett, N. L., Bethony, J., Bhatia, K., Bowen, J., Bryan, A. C., Cesarman, E., Casper, C., Chadburn, A., Cruz, M., Dittmer, D. P., Dyer, M. A., Farinha, P. & Gastier-Foster, J. M. & 48 others, Gerrie, A. S., Grande, B. M., Greiner, T., Griner, N. B., Gross, T. G., Harris, N. L., Irvin, J. D., Jaffe, E. S., Henry, D., Huppi, R., Leal, F. E., Lee, M. S., Martin, J. P., Martin, M. R., Mbulaiteye, S. M., Mitsuyasu, R., Morris, V., Mullighan, C. G., Mungall, A. J., Mungall, K., Mutyaba, I., Nokta, M., Namirembe, C., Noy, A., Ogwang, M. D., Omoding, A., Orem, J., Ott, G., Petrello, H., Pittaluga, S., Phelan, J. D., Ramos, J. C., Ratner, L., Reynolds, S. J., Rubinstein, P. G., Sissolak, G., Slack, G., Soudi, S., Swerdlow, S. H., Traverse-Glehen, A., Wilson, W. H., Wong, J., Yarchoan, R., ZenKlusen, J. C., Marra, M. A., Staudt, L. M., Scott, D. W. & Morin, R. D., Feb 23 2023, In: Blood. 141, 8, p. 904-916 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

33 Scopus citations

Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia

Johnson, P. C., Woyach, J. A., Ulrich, A., Marcotte, V., Nipp, R. D., Lage, D. E., Nelson, A. M., Newcomb, R. A., Rice, J., Lavoie, M. W., Ritchie, C. S., Bartlett, N., Stephens, D. M., Ding, W., Owen, C., Stone, R., Ruppert, A. S., Mandrekar, S. J., Byrd, J. C. & El-Jawahri, A. & 2 others, Le-Rademacher, J. & Rosko, A., Jul 2023, In: Journal of Geriatric Oncology. 14, 6, 101538.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

Epperla, N., Zhao, Q., Karmali, R., Torka, P., Shea, L., Oh, T. S., Anampa-Guzmán, A., Reves, H., Tavakkoli, M., Greenwell, I. B., Hansinger, E., Umyarova, E., Annunzio, K., Sawalha, Y., Christian, B., Thomas, C., Barta, S. K., Geethakumari, P. R., Bartlett, N. L. & Grover, N. S. & 1 others, Olszewski, A. J., Sep 12 2023, In: Blood Advances. 7, 17, p. 5038-5046 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

5 Scopus citations

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Epperla, N., Switchenko, J., Bachanova, V., Gerson, J. N., Barta, S. K., Gordon, M. J., Danilov, A. V., Grover, N. S., Mathews, S., Burkart, M., Karmali, R., Sawalha, Y., Hill, B. T., Ghosh, N., Park, S. I., Bond, D. A., Hamadani, M., Fenske, T. S., Martin, P. & Malecek, M. K. & 15 others, Kahl, B. S., Flowers, C. R., Link, B. K., Kaplan, L. D., Inwards, D. J., Feldman, A. L., Hsi, E. D., Maddocks, K., Blum, K. A., Bartlett, N. L., Cerhan, J. R., Leonard, J. P., Habermann, T. M., Maurer, M. J. & Cohen, J. B., Jun 13 2023, In: Blood Advances. 7, 11, p. 2287-2296 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis

Torka, P., Pederson, L. D., Knopp, M. V., Poon, D., Zhang, J., Kahl, B. S., Higley, H. R., Kelloff, G., Friedberg, J. W., Schwartz, L. H., Wilson, W. H., Leonard, J. P., Bartlett, N. L., Schöder, H. & Ruppert, A. S., Apr 2023, In: Cancer medicine. 12, 7, p. 8211-8217 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

Bartlett, N. L., Assouline, S., Giri, P., Schuster, S. J., Cheah, C. Y., Matasar, M., Gregory, G. P., Yoon, D. H., Shadman, M., Fay, K., Yoon, S. S., Panizo, C., Flinn, I., Johnston, A., Bosch, F., Sehn, L. H., Wei, M. C., Yin, S., To, I. & Li, C. C. & 4 others, Huang, H., Kwan, A., Penuel, E. & Budde, L. E., Sep 12 2023, In: Blood Advances. 7, 17, p. 4926-4935 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

Russler-Germain, D. A., Krysiak, K., Ramirez, C., Mosior, M., Watkins, M. P., Gomez, F., Skidmore, Z. L., Trani, L., Gao, F., Geyer, S., Cashen, A. F., Mehta-Shah, N., Kahl, B. S., Bartlett, N. L., Alderuccio, J. P., Lossos, I. S., Ondrejka, S. L., Hsi, E. D., Martin, P. & Leonard, J. P. & 3 others, Griffith, M., Griffith, O. L. & Fehniger, T. A., Sep 26 2023, In: Blood Advances. 7, 18, p. 5524-5539 16 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study

Kuruvilla, J., Armand, P., Hamadani, M., Kline, J., Moskowitz, C. H., Avigan, D., Brody, J. D., Ribrag, V., Herrera, A. F., Morschhauser, F., Kanate, A., Zinzani, P. L., Bitran, J., Ghesquieres, H., Schuster, S. J., Farooqui, M., Marinello, P. & Bartlett, N. L., 2023, In: Leukemia and Lymphoma. 64, 1, p. 130-139 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)

LaCasce, A. S., Dockter, T., Ruppert, A. S., Kostakoglu, L., Schöder, H., Hsi, E., Bogart, J., Cheson, B., Wagner-Johnston, N., Abramson, J., Blum, K., Leonard, J. P. & Bartlett, N. L., Feb 10 2023, In: Journal of Clinical Oncology. 41, 5, p. 1023-1034 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Lakhotia, R., Dunleavy, K., Abramson, J. S., Link, B. K., Powell, B. L., Melani, C., Lucas, A. N., Steinberg, S. M., Friedberg, J. W., Kahl, B. S., Little, R. F., Bartlett, N. L., Noy, A., Wilson, W. H. & Roschewski, M., Sep 26 2023, In: Blood Advances. 7, 18, p. 5320-5324 5 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials

Rutherford, S. C., Yin, J., Pederson, L., Perez Burbano, G., Laplant, B., Shadman, M., Li, H., Leblanc, M. L., Kenkre, V. P., Hong, F., Blum, K. A., Dockter, T., Martin, P., Jung, S. H., Grant, B., Rosenbaum, C., Ujjani, C., Barr, P. M., Unger, J. M. & Cheson, B. D. & 5 others, Bartlett, N. L., Kahl, B., Friedberg, J. W., Mandrekar, S. J. & Leonard, J. P., Jan 10 2023, In: Journal of Clinical Oncology. 41, 2, p. 336-342 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma

Gomez, F., Fisk, B., McMichael, J. F., Mosior, M., Foltz, J. A., Skidmore, Z. L., Duncavage, E. J., Miller, C. A., Abel, H., Li, Y. S., Russler-Germain, D. A., Krysiak, K., Watkins, M. P., Ramirez, C. A., Schmidt, A., Rodrigues, F. M., Trani, L., Khanna, A., Wagner, J. A. & Fulton, R. S. & 11 others, Fronick, C. C., O'Laughlin, M. D., Schappe, T., Cashen, A. F., Mehta-Shah, N., Kahl, B. S., Walker, J., Bartlett, N. L., Griffith, M., Fehniger, T. A. & Griffith, O. L., Nov 2023, In: Cancer research communications. 3, 11, p. 2312-2330 19 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

2022

Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience

Bennani, N. N., Tun, A. M., Carson, K. R., Geiger, J. L., Maeda, L. S., Savage, K. J., Rose, J., Pinter-Brown, L., Lunning, M. A., Abramson, J. S., Bartlett, N. L., Vose, J. M., Evens, A. M., Smith, S. M., Horwitz, S. M., Ansell, S. M. & Advani, R. H., May 1 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 5, p. e300-e309

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience

Bennani, N. N., Tun, A. M., Carson, K. R., Geiger, J. L., Maeda, L. S., Savage, K. J., Rose, J., Pinter-Brown, L., Lunning, M. A., Abramson, J. S., Bartlett, N. L., Vose, J. M., Evens, A. M., Smith, S. M., Horwitz, S. M., Ansell, S. M. & Advani, R. H., Apr 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 4, p. e250-e260

Research output: Contribution to journal › Article › peer-review

Open Access

HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)

Carlo-Stella, C., Ansell, S., Zinzani, P. L., Radford, J., Maddocks, K., Pinto, A., Collins, G. P., Bachanova, V., Bartlett, N., Bence-Bruckler, I., Hamadani, M., Kline, J., Mayer, J., Savage, K. J., Advani, R., Calmi, P., Casasnovas, R. O., Feldman, T., Hess, B. & Bastos-Oreiro, M. & 6 others, Iyengar, S., Eisen, S., Negievich, Y., Wang, L., Wuerthner, J. & Herrera, A. F., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S347

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1

Straus, D., Radford, J., Connors, J., Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J., Advani, R., Hutchings, M., Evens, A., Smolewski, P., Savage, K., Bartlett, N., Eom, H. S., Abramson, J., Dong, C., Campana, F., Fenton, K., Puhlmann, M. & Ansell, S., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S350

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study

Budde, E. L., Sehn, L. H., Matasar, M., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Canales, M., Dietrich, S., Fay, K., Ku, M., Nastoupil, L., Wei, M. C., Yin, S., Doral, M. Y., Li, C. C., Huang, H., Negricea, R., Penuel, E. & O'Hear, C. & 1 others, Bartlett, N. L., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S387

Research output: Contribution to journal › Article › peer-review

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Harkins, R. A., Patel, S. P., Lee, M. J., Switchenko, J. M., Ansell, S. M., Bartlett, N. L., Blum, K. A., Cashen, A. F., Casulo, C., Friedberg, J. W., Johnston, P. B., Kahl, B. S., Leonard, J. P., Link, B. K., Lossos, I. S., Martin, P., Maurer, M. J., Mehta-Shah, N., Reagan, P. M. & Westin, J. R. & 2 others, Koff, J. L. & Flowers, C. R., May 10 2022, In: Blood Advances. 6, 9, p. 2745-2756 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Jaswal, S., Sanders, V., Pullarkat, P., Teja, S., Albright, A., Watkins, M. P., Atagu, N., Ludwig, D. R., Mhlanga, J., Mellnick, V. M., Peterson, L. R., Bartlett, N. L., Kahl, B. S., Fehniger, T. A., Ghobadi, A., Cashen, A. F., Mehta-Shah, N. & Ippolito, J. E., Jun 1 2022, In: Cancers. 14, 12, 2932.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience

Hamid, M. S., Rutherford, S. C., Jang, H., Kim, S., Patel, K., Bartlett, N. L., Malecek, M. K., Watkins, M. P., Maddocks, K. J., Bond, D. A., Feldman, T. A., Magarelli, G., Advani, R. H., Spinner, M. A., Evens, A. M., Shah, M., Ahmed, S., Stephens, D. M., Allen, P. & Tees, M. T. & 7 others, Karmali, R., Cheson, B. D., Yazdy, M. S., Strouse, C., Bailey, N. A., Pagel, J. M. & Ramchandren, R., Jul 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 7, p. e435-e442

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

the ECHELON-1 Study Group, Jul 28 2022, In: New England Journal of Medicine. 387, 4, p. 310-320 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

160 Scopus citations

Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma

Halwani, A. S., Panizo, C., Isufi, I., Herrera, A. F., Okada, C. Y., Cull, E. H., Kis, B., Chaves, J. M., Bartlett, N. L., Ai, W., de la Cruz-Merino, L., Bryan, L. J., Houot, R., Linton, K., Briones, J., Chau, I., von Keudell, G. R., Lu, H., Yakovich, A. & Chen, M. & 4 others, Meulen JH, T., Yurasov, S., Hsu, F. J. & Flowers, C. R., 2022, In: Leukemia and Lymphoma. 63, 4, p. 821-833 13 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

Ward, J. P., Berrien-Elliott, M. M., Gomez, F., Luo, J., Becker-Hapak, M., Cashen, A. F., Wagner-Johnston, N. D., Maddocks, K., Mosior, M., Foster, M., Krysiak, K., Schmidt, A., Skidmore, Z. L., Desai, S., Watkins, M. P., Fischer, A., Griffith, M., Griffith, O. L., Fehniger, T. A. & Bartlett, N. L., Mar 31 2022, In: Blood. 139, 13, p. 1999-2010 12 p.

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

Martin, P., Bartlett, N. L., Chavez, J. C., Reagan, J. L., Smith, S. M., LaCasce, A. S., Jones, J., Drew, J., Wu, C., Mulvey, E., Revuelta, M. V., Cerchietti, L. & Leonard, J. P., Feb 24 2022, In: Blood. 139, 8, p. 1147-1159 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

22 Scopus citations

Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

Jagadeesh, D., Horwitz, S., Bartlett, N. L., Kim, Y., Jacobsen, E., Duvic, M., Little, M., Trepicchio, W., Fenton, K., Onsum, M., Lisano, J. & Advani, R., Oct 2022, In: Oncologist. 27, 10, p. 864-873 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Scopus citations

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Budde, L. E., Sehn, L. H., Matasar, M., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Canales, M., Dietrich, S., Fay, K., Ku, M., Nastoupil, L., Cheah, C. Y., Wei, M. C., Yin, S., Li, C. C., Huang, H., Kwan, A., Penuel, E. & Bartlett, N. L., Aug 2022, In: The Lancet Oncology. 23, 8, p. 1055-1065 11 p.

Research output: Contribution to journal › Article › peer-review

191 Scopus citations

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients with Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

Budde, L. E., Assouline, S., Sehn, L. H., Schuster, S. J., Yoon, S. S., Yoon, D. H., Matasar, M. J., Bosch, F., Kim, W. S., Nastoupil, L. J., Flinn, I. W., Shadman, M., Diefenbach, C., O'Hear, C., Huang, H., Kwan, A., Li, C. C., Piccione, E. C., Wei, M. C. & Yin, S. & 1 others, Bartlett, N. L., Feb 10 2022, In: Journal of Clinical Oncology. 40, 5, p. 481-491 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

201 Scopus citations

Six-Year Results from RELEVANCE: Lenalidomide Plus Rituximab (R²) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

Morschhauser, F., Nastoupil, L., Feugier, P., De Colella, J. M. S., Tilly, H., Palomba, M. L., Bachy, E., Fruchart, C., Libby, E. N., Casasnovas, R. O., Flinn, I. W., Haioun, C., Maisonneuve, H., Ysebaert, L., Bartlett, N. L., Bouabdallah, K., Brice, P., Ribrag, V., Le Gouill, S. & Daguindau, N. & 17 others, Guidez, S., Pica, G. M., García-Sancho, A. M., López-Guillermo, A., Larouche, J. F., Ando, K., Gomes Da Silva, M., André, M., Kalung, W., Sehn, L. H., Izutsu, K., Cartron, G., Gkasiamis, A., Crowe, R., Xerri, L., Fowler, N. H. & Salles, G., Oct 1 2022, In: Journal of Clinical Oncology. 40, 28, p. 3239-3245 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

25 Scopus citations

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

Horwitz, S., O'Connor, O. A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T., Menne, T., Belada, D., Illés, Tobinai, K., Tsukasaki, K., Yeh, S. P. & Shustov, A. & 10 others, Hüttmann, A., Savage, K. J., Yuen, S., Zinzani, P. L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M. & Illidge, T., Mar 2022, In: Annals of Oncology. 33, 3, p. 288-298 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

132 Scopus citations

2021

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

Ruppert, A. S., Booth, A. M., Ding, W., Bartlett, N. L., Brander, D. M., Coutre, S., Brown, J. R., Nattam, S., Larson, R. A., Erba, H., Litzow, M., Owen, C., Kuzma, C. S., Abramson, J. S., Little, R. F., Smith, S. E., Stone, R. M., Byrd, J. C., Mandrekar, S. J. & Woyach, J. A., Oct 2021, In: Leukemia. 35, 10, p. 2854-2861 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

B-cell lymphomas, version 5.2021. Featured updates to the NCCN guidelines

Zelenetz, A. D., Gordon, L. I., Chang, J. E., Christian, B., Abramson, J. S., Advani, R. H., Bartlett, N. L., Budde, L. E., Caimi, P. F., de Vos, S., Dholaria, B., Fakhri, B., Fayad, L. E., Glenn, M. J., Habermann, T. M., Hernandez-Ilizaliturri, F., Hsi, E., Hu, B., Kaminski, M. S. & Kelsey, C. R. & 17 others, Khan, N., Krivacic, S., LaCasce, A. S., Lim, M., Narkhede, M., Rabinovitch, R., Ramakrishnan, P., Reid, E., Roberts, K. B., Saeed, H., Smith, S. D., Svoboda, J., Swinnen, L. J., Tuscano, J., Vose, J. M., Dwyer, M. A. & Sundar, H., Nov 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 11, p. 1218-1230 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

97 Scopus citations

Biomarkers for Risk Stratification in Patients with Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy

Sohani, A. R., Maurer, M. J., Giri, S., Pitcher, B., Chadburn, A., Said, J. W., Bartlett, N. L., Czuczman, M. S., Martin, P., Rosenbaum, C. A., Jung, S. H., Leonard, J. P., Cheson, B. D. & Hsi, E. D., Mar 2021, In: American Journal of Surgical Pathology. 45, 3, p. 384-393 10 p.

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results

Advani, R. H., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R., Feldman, T. A., LaCasce, A. S., Christian, B. A., Ansell, S. M., Moskowitz, C. H., Brown, L., Zhang, C., Taft, D., Ansari, S., Sacchi, M., Ho, L. & Herrera, A. F., Aug 12 2021, In: Blood. 138, 6, p. 427-438 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

130 Scopus citations

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Straus, D. J., Długosz-Danecka, M., Connors, J. M., Alekseev, S., Illés, Á., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Ramchandren, R., Zinzani, P. L., Hutchings, M., Munoz, J., Lee, H. J., Kim, W. S., Advani, R. & Ansell, S. M. & 7 others, Younes, A., Gallamini, A., Liu, R., Little, M., Fenton, K., Fanale, M. & Radford, J., Jun 2021, In: The Lancet Haematology. 8, 6, p. e410-e421

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder

Krishnamoorthy, S., Ghobadi, A., Santos, R. D., Schilling, J. D., Malone, A. F., Murad, H., Bartlett, N. L. & Alhamad, T., Feb 2021, In: American Journal of Transplantation. 21, 2, p. 809-814 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

53 Scopus citations

Nancy Bartlett

Research output

Search results